Federal contractor · WEBSTER, TX

TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC

TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC received $4.1M in federal contract obligations in FY2026, on 3 awards. Its largest customer was Food and Drug Administration ($4.1M).

Obligations · FY2026
$4.1M
New awards
3
Sole-source
0.0%
Single offer
0.0%
UEI
FWWJT8QCEDY4
Small businessMinority-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 4.1MFY2026

Top buying agencies

Obligations in FY2026.

  1. Food and Drug Administration$4.1M100%
    3 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$4.1M100%

Where the work was performed

  1. Harris County, TX$2.9M70%
  2. Montgomery County, MD$1.2M30%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. DDI CLINICAL PHARMACOLOGY STUDY$1.6M
    Food and Drug Administration· Harris County, TX· Research & development· Sep 22, 2026 – Sep 22, 2026· 75F40126F19005
  2. SUNSCREEN ABSORPTION CLINICAL PHARMACOLOGY STUDY$1.3M
    Food and Drug Administration· Harris County, TX· Research & development· Sep 21, 2026 – Sep 21, 2026· 75F40126F19004
  3. FFP TASK ORDER FOR PROTON PUMP INHIBITOR PK STUDY FOR THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF GENERIC DRUGS (OGD).$1.2M
    Food and Drug Administration· Montgomery County, MD· Research & development· Sep 29, 2026 – Sep 29, 2026· 75F40126F19001

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. ROCHESTER INSTITUTE OF TECHNOLOGY$4.2M−99% in FY2026
    ROCHESTER, NY · 100% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  2. APTARGROUP INC$3M+81% in FY2026
    CONGERS, NY · 71% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  3. THE CRITICAL PATH INSTITUTE$2.7M−79% in FY2026
    TUCSON, AZ · 65% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.